Suppr超能文献

1985 - 1995年芬兰的心脏移植

Heart transplantation in Finland 1985-1995.

作者信息

Mattila S, Heikkilä L, Sipponen J, Verkkala K, Kyösola K, Mattila T, Järvinen A, Luosto R, Heikkinen L, Ketonen P, Salo J, Nemlander A, Mattila I, Nieminen M S

机构信息

Department of Thoracic and Cardiovascular Surgery, Helsinki University Central Hospital, Finland.

出版信息

Ann Chir Gynaecol. 1997;86(2):113-20.

PMID:9366983
Abstract

BACKGROUND AND AIMS

Since improved immunosuppression in the 1980's, heart transplantation is a well established procedure to treat patients with end-stage heart failure. The first heart transplantation in Finland was performed in 1985. Since then the activity has gradually increased to a level of about 25 annual transplants. The aim of this report is to sum up the clinical experience during the first 11 years.

MATERIALS AND METHODS

From February 1985 till the end of 1995, 190 heart transplantations were performed in our institution. There were 176 males and 14 females ranging from 15 to 62 (mean 42.2) years of age. End-stage preoperative cardiac disease was dilating cardiomyopathy in 108 cases, coronary artery disease in 65 cases, valvular disease in 12 cases and congenital heart disease in five cases.

RESULTS

The 30-day hospital mortality was 29 out of 190 (15.2%). The actuarial survival was 77% at one year, 75% at two years and 73% at 10 years. The most common causes of death were rejection (11 cases), graft failure (11 cases), abdominal complications (six cases) and cytomegalovirus (CMV) infection (four cases). A total of 87 rejection episodes occurred in 53 patients consisting 28 per cent of patients. 44 rejections occurred within three months post transplantation. Significant infections were noted in 198 instances in 97 patients. These were of bacterial origin in 92, viral in 48, fungal in 12 and protozoal in 10 cases, and 36 such infections which responded to antibiotics favourably but in which the microbe remained unidentified. 138 infections (i.e. 80%) occurred within 6 months post transplantation. In viral infections cytomegalovirus (CMV) predominated (29 out of 48). The CMV infection was significantly milder in patients who were seropositive preoperatively than in preoperatively seronegative patients with seropositive donors. CMV infection was associated with increased risk of post-transplant coronary artery disease. Three years after transplantation some restoration of sympathetic nervous response was observed at orthostatic test in heart rate and blood pressure.

CONCLUSIONS

It can be concluded that 1) if a patient survives the three immediate postoperative months, his prognosis is good for the forthcoming years, 2) clinically significant rejections occur in less than one third of the patients, 3) cytomegalovirus is the most harmful agent post transplantation and a risk factor for post-transplant coronary artery disease and that 4) some restoration of sympathetic nervous control of the heart occurs within three years after transplantation.

摘要

背景与目的

自20世纪80年代免疫抑制治疗得到改善以来,心脏移植已成为治疗终末期心力衰竭患者的一种成熟方法。芬兰首例心脏移植于1985年进行。从那时起,心脏移植活动逐渐增加,达到每年约25例的水平。本报告的目的是总结最初11年的临床经验。

材料与方法

从1985年2月至1995年底,我们机构共进行了190例心脏移植手术。其中男性176例,女性14例,年龄在15至62岁之间(平均42.2岁)。术前终末期心脏疾病包括扩张型心肌病108例、冠状动脉疾病65例、瓣膜疾病12例和先天性心脏病5例。

结果

190例患者中有29例(15.2%)在术后30天内死亡。1年时的精算生存率为77%,2年时为75%,10年时为73%。最常见的死亡原因是排斥反应(11例)、移植物功能衰竭(11例)、腹部并发症(6例)和巨细胞病毒(CMV)感染(4例)。53例患者共发生87次排斥反应,占患者总数的28%。44次排斥反应发生在移植后三个月内。97例患者共发生198次严重感染。其中细菌感染92例,病毒感染48例,真菌感染12例,原虫感染10例,36例感染对抗生素反应良好但病原体未明确。138例感染(即80%)发生在移植后6个月内。病毒感染中以巨细胞病毒(CMV)为主(48例中的29例)。术前血清学阳性的患者CMV感染明显比术前血清学阴性且供体血清学阳性的患者轻。CMV感染与移植后冠状动脉疾病风险增加有关。移植三年后,在直立试验中观察到心率和血压的交感神经反应有所恢复。

结论

可以得出以下结论:1)如果患者术后前三个月存活,其未来几年的预后良好;2)临床上有意义的排斥反应发生在不到三分之一的患者中;3)巨细胞病毒是移植后最有害的因素,也是移植后冠状动脉疾病的危险因素;4)移植后三年内心脏的交感神经控制有所恢复。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验